Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

Hertl, M.; Jedlickova, H.; Karpati, S.; Marinovic, B.; UZUN, SONER; YAYLI, SAVAŞ; Mimouni, D.; Borradori, L.; Feliciani, C.; Ioannides, D.; Joly, P.; Kowalewski, C.; Zambruno, G.; Zillikens, D.; Jonkman, M.

doi:10.1111/jdv.12772

Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

Hertl M., Jedlickova H., Karpati S., Marinovic B., UZUN S., YAYLI S., ...Daha Fazla

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, cilt.29, sa.3, ss.405-414, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 29 Sayı: 3
Basım Tarihi: 2015
Doi Numarası: 10.1111/jdv.12772
Dergi Adı: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.405-414
Akdeniz Üniversitesi Adresli: Evet

Özet

BackgroundPemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost fatal. Due to its rarity, only few prospective controlled therapeutic trials are available.